SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sea Limited – SE
NEW YORK, June 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sea Limited (“Sea” or the “Company”) (NYSE: SE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The invest
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ecopetrol S.A. – EC
NEW YORK, June 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ecopetrol S.A. (“Ecopetrol” or the “Company”) (NYSE: EC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. Th
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hesai Group – HSAI
NEW YORK, June 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. – REGN
NEW YORK, June 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeutics, Inc. – BOLT
NEW YORK, June 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Bolt Biotherapeutics, Inc. (“Bolt” or the “Company”) (NASDAQ: BOLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, e
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. – MGNX
NEW YORK, June 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. (“MacroGenics” or the “Company”) (NASDAQ: MGNX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext
Flow Diversion Aneurysm Treatment Market size is set to grow by USD 2.43 billion from 2024-2028, Increasing incidence of intracranial aneurysms boost the market, Technavio
NEW YORK, June 24, 2024 /PRNewswire/ — The global flow diversion aneurysm treatment market size is estimated to grow by USD 2.43 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 9.34% during the forecast period. The flow diversion aneurysm tr
E-Mail Encryption Market size is set to grow by USD 16.03 billion from 2024-2028, High adoption of cloud-based services to boost the market growth, Technavio
NEW YORK, June 24, 2024 /PRNewswire/ — The global E-mail encryption market size is estimated to grow by USD 16.03 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 32.4% during the forecast period. The email encryption market is thrivi
Paper Starch Market size is set to grow by USD 7.12 billion from 2024-2028, Increasing demand for printing and writing papers in education sector to boost the market growth, Technavio
NEW YORK, June 24, 2024 /PRNewswire/ — The global paper starch market size is estimated to grow by USD 7.12 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 5.17% during the forecast period. The paper starch market is on an upward trajecto
Cohen & Steers Closed-End Funds Declare Distributions for July, August, and September 2024
NEW YORK, June 24, 2024 /PRNewswire/ — The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for July, August, and September 2024, as summarized in the charts below: Ticker Fund Name Monthly Dividend FOF Cohen & Steers Closed-End Oppor
